LASER NANOFAB GMBH

Their core work

Laser Nanofab GmbH is a German technology SME specializing in precision laser-based nanofabrication, applied specifically to the production of biocompatible 3D scaffolds for neural and tissue engineering applications. Their commercial focus is on manufacturing scaffold platforms that serve as substrates for human-derived iPSC (induced pluripotent stem cell) cultures, targeting both disease modeling and safety testing markets. In the H2020 program, they contributed fabrication expertise to projects developing in-vitro models of the peripheral nervous system for use in medical research and cosmetic/dermatological testing — areas where animal testing alternatives are increasingly demanded. Their value to consortia is the translation of laboratory scaffold designs into reproducible, manufacturable structures that biology teams can actually use.

What they specialise in

How they've shifted over time

Laser Nanofab has only two H2020 projects, both starting between 2019 and 2020, so there is no meaningful early-period baseline to compare against — the keyword data confirms no retrievable early-phase activity. Within the observable window, there is a clear deepening from a relatively broad "commercialization of 3D scaffold platforms" framing (SCAFFOLD-NEEDS, 2019) toward more biologically specific applications involving iPSC cells, ALS disease modeling, and cosmetic testing (PLATFORMA, 2020). This suggests the company is moving from fabrication-as-a-service toward co-developing application-specific platforms with life science partners — a shift from manufacturer to technology enabler.

They are moving deeper into life science applications — specifically neural disease modeling and regulatory-grade in-vitro testing — which points toward future work in organ-on-chip, next-generation cosmetic safety testing, and neurodegenerative disease research consortia.

How they like to work

Laser Nanofab participates exclusively as a consortium partner — they have never led an H2020 project — which is consistent with a technology supplier role: they bring a specific manufacturing capability that other partners (typically academic biology groups or clinical institutes) depend on. Their network is notably small: five unique partners across three countries across two projects, suggesting they work in tight, specialist consortia rather than large multi-stakeholder networks. This is typical of niche deep-tech SMEs where the value is highly specific and not easily substituted.

Laser Nanofab has worked with five unique partners across three countries, indicating a compact and focused European network rather than a broad one. Their geographic reach is European but concentrated, likely anchored around German and neighboring research institutions given their base in the Hanover region.

What sets them apart

Laser Nanofab sits at a rare intersection: precision laser nanofabrication combined with direct application to biomedical scaffold production — a combination that most biology-focused partners cannot replicate internally. For consortia building in-vitro neural or skin testing platforms, they offer a ready manufacturing capability that bridges material science and cell biology without requiring a university fabrication facility. Their SME status and commercial orientation also mean they are motivated to push toward market-ready products, not just publishable results.

Highlights from their portfolio

• PLATFORMA
  The largest project by far (€419,050 EC funding), targeting peripheral nervous system tissue engineering with iPSC cells for both medical and cosmetic testing — a commercially high-value application given EU restrictions on animal testing in cosmetics.
• SCAFFOLD-NEEDS
  An earlier-stage commercialization project that established Laser Nanofab's position in the neuronal cell culture scaffold market, serving as the foundation for their more advanced work in PLATFORMA.